hsa-miR-222
Submitted by Anonymous on Wed, 10/30/2019 - 22:16
Pubmed
Gene symble | Title | PMID | Curated descirption | Category | Literature category |
---|---|---|---|---|---|
hsa-miR-222 | Exosome-mediated hsa-miR-222 transferring: An insight into NF-B-mediated breast cancer metastasis | 29778754 | Hsa-miR-222 contributes to tumorigenicity of BCa cells through down-regulation of PDLIM2 and consequently activating NF-κB | mechanism | BCEXO research |
hsa-miR-222 | Exosomes from Drug-Resistant Breast Cancer Cells Transmit Chemoresistance by a Horizontal Transfer of MicroRNAs | 24740415 | Hsa-miR-222-rich D/exo could alter PTEN expression in acquired cells that may spread resistance capacity | mechanism | BCEXO research |
hsa-miR-222 | Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy | 30728048 | Higher levels of exosomal miRNA-21, miRNA-222, and miRNA-155 were significantly associated with the presence of circulating tumor cells;Liquid biopsies based on exosomal miRNAs and circulating tumor cells can be a complementary clinical tool for improving breast cancer diagnosis and prognosis | biomarker | BCEXO research |
hsa-miR-222 | MicroRNAs miR-221 and miR-222: a new level of regulation in aggressive breast cancer | 21888691 | MiR-221/222 in breast cancer metastasis, drug resistance and RAS pathways could potentially have applications in medical practice | mechanism | BC/OC research |
hsa-miR-222 | miR-221/222: promising biomarkers for breast cancer | 23529451 | MiR-221/222 act as promising biomarkers for BCa and they would offer a new way in molecular targeting cancer treatment | biomarker | BC/OC research |
hsa-miR-222 | MiR-222 promotes drug-resistance of breast cancer cells to adriamycin via modulation of PTEN/Akt/FOXO1 pathway | 27746366 | Inhibition of miR-222 may improve the prognosis of breast cancer patients | biomarker | BC/OC research |
hsa-miR-222 | MiR-222 promotes drug-resistance of breast cancer cells to adriamycin via modulation of PTEN/Akt/FOXO1 pathway | 27746366 | MiR-222 mediated ADR-resistance of breast cancer cells partly through regulation of PTEN/Akt/FOXO1 signaling pathway | mechanism | BC/OC research |
hsa-miR-222 | Expression Analysis of MicroRNA-222 in Breast Cancer | 29739090 | Our findings on miR-222 suggest that it could be a potentially useful target for control and management of breast malignancy | biomarker | BC/OC research |
hsa-miR-222 | miR-221/222 activate the Wnt/β-catenin signaling to promote triple-negative breast cancer | 30053090 | MiR-221/222 activate the Wnt/β-catenin signaling to promote the aggressiveness and TNBC properties of breast cancers, and thus reveal a new prospect for TNBC treatment | mechanism | BC/OC research |
Survival analysis
Pathways
Enriched Terms | Cross Refer. |
---|---|
p53 signaling pathway | KEGG |
Valine, leucine and isoleucine biosynthesis | KEGG |
Allograft rejection | KEGG |
Glioma | KEGG |
Sulfur relay system | KEGG |
Proteoglycans in cancer | KEGG |
Antigen processing and presentation | KEGG |
mRNA surveillance pathway | KEGG |
Cell cycle | KEGG |
Lysine degradation | KEGG |